Defining high-risk LUAD subtypes with large-scale RWDRWD analysis identifies six LUAD subtypes, including a high-risk group with poor outcomesINDICATIONLungRelated casesIL33 expression as a predictor of immunotherapy response in NSCLCImpact of B cell and CD8 T cell infiltration on immunotherapy outcomes in NSCLCImpact of VEGF expression on pembrolizumab outcomes in mNSCLC